Results 121 to 130 of about 32,506 (196)

Machine Learning-Based Prediction of Transthyretin-Binding Activity and Its Application to Screening Food-Derived Compounds for ATTR Amyloidosis. [PDF]

Pharmaceuticals (Basel)
Iwashita Y, Uesawa Y.
europepmc   +1 more source

Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan. [PDF]

Intern Med, 2023
Matsushima M, Tarisawa M, Nomura T, Oshima Y, Yoshino M, Shibata Y, Wakita M, Shirai S, Iwata I, Yaguchi H, Yabe I.   +10 more
europepmc   +1 more source

Clinical safety and tolerability of <i>in vivo</i> gene editing drug ART001 for ATTR amyloidosis. [PDF]

Front Med (Lausanne)
Jiang Y, Huang L, Qiu H, Yang S, Tao J, Chen R, Hao Y.   +6 more
europepmc   +1 more source

Contemporary Description of Clinical Characteristics and Outcomes in Patients with Hereditary ATTR Amyloidosis: Results from the Multicountry OverTTuRe Study. [PDF]

Cardiol Ther
Alexander KM, Kohsaka S, Poulsen SH, Terkelsen AJ, Smith JG, Sundström J, Wright J, Järbrink K, Bhimjiyani AG, Davis L, Matsue Y, Anderson LJ, Pilebro B.   +12 more
europepmc   +1 more source

Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare professionals. [PDF]

BMJ Open, 2023
Obici L, Callaghan R, Ablett J, Bibiloni C, Bueser T, Conceição I, Dongiglio F, Farrugia A, Knebel F, Lane T, Larsson LO, Morier A, Nicholas V, Coelho T.   +13 more
europepmc   +1 more source

Co-Existing ATTR Amyloidosis and Coronary Artery Disease: A Risky Combination. [PDF]

Clin Case Rep
Planchat A, Guijarro D, Musayeb Y, Giannakopoulos G, Giraud R, Poku NK, Py DA, Noble S.   +7 more
europepmc   +1 more source

Early timepoint ^99mTc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosis. [PDF]

EJNMMI Res
Settelmeier S, Kessler L, Hammersen N, Papathanasiou M, Rischpler C, Carpinteiro A, Oubari S, Michel L, Vogel J, Wollenweber T, Ning J, Hacker M, Spielvogel CP, Varasteh Z, Fendler WP, Barbato F, Costa PF, Leyser S, Rassaf T, Herrmann K, Telli T, Kersting D.   +21 more
europepmc   +1 more source

Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study. [PDF]

Circulation
Razvi Y, Rauf MU, Porcari A, Mansell J, Sheikh A, Ioannou A, Whelan CJ, Venneri L, Martinez-Naharro A, Hutt DF, Rowczenio D, Gilbertson JA, Wechalekar AD, Lachmann HJ, Hawkins PN, Fontana M, Gillmore JD.   +16 more
europepmc   +1 more source

The FLC Ratio Reframed: Averting Unnecessary Heart Biopsies in Wild-Type ATTR Amyloidosis. [PDF]

JACC CardioOncol
Muchtar E, Maurer MS.
europepmc   +1 more source

ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review. [PDF]

JACC CardioOncol, 2021
Griffin JM, Rosenthal JL, Grodin JL, Maurer MS, Grogan M, Cheng RK.   +5 more
europepmc   +1 more source